Skip to main content
Clinical Trials/NL-OMON36640
NL-OMON36640
Recruiting
Not Applicable

Reduction of asthma exacerbation rate in children by non-invasive monitoring of inflammatory markers in exhaled breath (condensate): the RASTER study - Monitoring of childhood asthma by non-invasive inflammatory markers

Medisch Universitair Ziekenhuis Maastricht0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
allergic asthma
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • The specific inclusion criteria are: 1\) already known with a diagnosis of asthma during at least 6 months; 2\) age between 6 and 16 years; 3\) reversibility to a bronchodilator (increase in FEV1 \> 9% of predicted value; and/or 4\) bronchial hyperresponsiveness to PC20 histamine \< 8 mg/ml; and/or 5\)only the use of fluticason in case of inhaled corticosteroid therapy and 6\) the use of inhaled corticosteroids.

Exclusion Criteria

  • Exclusion criteria are: 1\) cardiac abnormalities; 2\) mental retardation, congenital abnormalities or existence of a syndrome; 3\) active smoking; 4\) no technical satisfactory performance of measurements; 5\) no phone line or internet assess available at home; 6\) allergen immunotherapy during the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials